Cytosorbents Corp - Common Stock (CTSO)

CUSIP: 23283X206

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock
Shares outstanding
63,013,241
Total 13F shares
3,206,188
Share change
+724,310
Total reported value
$20,847,000
Put/Call ratio
114%
Price per share
$6.50
Number of holders
43
Value change
+$4,718,786
Number of buys
33
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 23283X206?
CUSIP 23283X206 identifies CTSO - Cytosorbents Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CTSO - Cytosorbents Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
1.3%
799,932
$4,960,000 30 Sep 2017
13F
Skylands Capital, LLC
13F
Company
0.79%
500,050
$3,100,000 30 Sep 2017
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.28%
179,004
$1,110,000 30 Sep 2017
13F
Manatuck Hill Partners, LLC
13F
Company
0.24%
150,000
$930,000 30 Sep 2017
13F
BlackRock Finance, Inc.
13F
Company
0.22%
136,817
$848,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.2%
127,125
$788,000 30 Sep 2017
13F
PEAK6 Group LLC
13F
Company
0.12%
74,622
$463,000 30 Sep 2017
13F
Wealthcare Advisory Partners LLC
13F
Company
0.09%
58,899
$365,000 30 Sep 2017
13F
Virtu Financial LLC
13F
Company
0.09%
54,358
$337,000 30 Sep 2017
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.08%
50,000
$310,000 30 Sep 2017
13F
NORTHERN TRUST CORP
13F
Company
0.08%
48,765
$302,000 30 Sep 2017
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.07%
46,100
$286,000 30 Sep 2017
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.07%
41,217
$256,000 30 Sep 2017
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0.06%
39,100
$242,000 30 Sep 2017
13F
Bank of New York Mellon Corp
13F
Company
0.04%
25,519
$158,000 30 Sep 2017
13F
FORTALEZA ASSET MANAGEMENT INC/
13F
Company
0.04%
23,375
$145,000 30 Sep 2017
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0.03%
20,000
$124,000 30 Sep 2017
13F
WOLVERINE TRADING, LLC
13F
Company
0.03%
19,746
$122,000 30 Sep 2017
13F
GLENMEDE TRUST CO NA
13F
Company
0.03%
19,008
$117,000 30 Sep 2017
13F
Advisor Group, Inc.
13F
Company
0.03%
16,700
$104,000 30 Sep 2017
13F
SALEM INVESTMENT COUNSELORS INC
13F
Company
0.02%
13,000
$79,000 30 Sep 2017
13F
STATE STREET CORP
13F
Company
0.02%
12,000
$74,000 30 Sep 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
7,414
$46,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
0.01%
6,862
$43,000 30 Sep 2017
13F
IFP Advisors, Inc
13F
Company
0.01%
5,600
$35,000 30 Sep 2017
13F
ROYAL BANK OF CANADA
13F
Company
0%
2,800
$17,000 30 Sep 2017
13F
AVIANCE CAPITAL MANAGEMENT, LLC
13F
Company
0%
1,580
$10,000 30 Sep 2017
13F
Cable Hill Partners, LLC
13F
Company
0%
1,000
$6,000 30 Sep 2017
13F
THOMPSON DAVIS & CO., INC.
13F
Company
0%
1,000
$6,000 30 Sep 2017
13F
JPMORGAN CHASE & CO
13F
Company
0%
285
$2,000 30 Sep 2017
13F
GROUP ONE TRADING LLC
13F
Company
0%
254
$2,000 30 Sep 2017
13F

Institutional Holders of Cytosorbents Corp - Common Stock (CTSO) as of Q4 2017

As of 31 Dec 2017, Cytosorbents Corp - Common Stock (CTSO) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,206,188 shares. The largest 10 holders included Vanguard Group Inc, Skylands Capital, LLC, Manatuck Hill Partners, LLC, MILLENNIUM MANAGEMENT LLC, B. Riley Financial, Inc., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, PEAK6 Investments, L.P., and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 43 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
30
Q4 2017 holders
43
Holder diff
13
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .